FIORCARI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.152
EU - Europa 1.248
AS - Asia 359
SA - Sud America 7
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.771
Nazione #
US - Stati Uniti d'America 3.139
GB - Regno Unito 525
IT - Italia 225
SE - Svezia 161
CN - Cina 119
DE - Germania 112
SG - Singapore 79
HK - Hong Kong 76
UA - Ucraina 60
FI - Finlandia 51
TR - Turchia 46
BG - Bulgaria 28
FR - Francia 21
BE - Belgio 18
ID - Indonesia 14
CZ - Repubblica Ceca 12
CA - Canada 10
VN - Vietnam 9
RU - Federazione Russa 8
ES - Italia 7
JP - Giappone 6
RO - Romania 6
CL - Cile 4
NL - Olanda 4
AU - Australia 3
BZ - Belize 3
IE - Irlanda 3
IN - India 3
MY - Malesia 3
BR - Brasile 2
DK - Danimarca 2
HR - Croazia 2
IR - Iran 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
PK - Pakistan 1
PL - Polonia 1
Totale 4.771
Città #
Fairfield 521
Southend 446
Woodbridge 294
Ashburn 275
Chandler 254
Houston 244
Cambridge 208
Seattle 205
Wilmington 155
Ann Arbor 151
Nyköping 133
Dearborn 108
Modena 105
Jacksonville 102
Hong Kong 76
New York 46
Fremont 42
Singapore 38
Beijing 35
Helsinki 32
San Diego 30
Izmir 29
Princeton 29
Sofia 28
Bremen 26
Eugene 26
Brussels 18
London 15
Redwood City 15
Bologna 13
Jakarta 13
Falls Church 9
Phoenix 9
San Jose 9
Boardman 8
Brno 8
Dong Ket 8
Milan 8
Frankfurt am Main 7
San Giuliano Milanese 7
Castelnuovo Rangone 6
Chicago 6
Dallas 6
Des Moines 6
Madrid 6
Munich 6
Shanghai 6
Guangzhou 5
Hefei 5
Kilburn 4
Kunming 4
Norwalk 4
Ottawa 4
San Francisco 4
Amsterdam 3
Atlanta 3
Belize City 3
Castelnovo ne' Monti 3
Clearwater 3
Dublin 3
Las Vegas 3
Leawood 3
Los Angeles 3
Parma 3
Reggio Emilia 3
Toronto 3
Verona 3
Albuquerque 2
Ancona 2
Boretto 2
Chiswick 2
Constanta 2
Dongguan 2
Fasano 2
Freiburg 2
Fukushima 2
Fuzhou 2
Hounslow 2
Indiana 2
Jinan 2
Jinhua 2
Lappeenranta 2
Martina Franca 2
Montréal 2
Olomouc 2
Osimo 2
Saint Louis 2
Santiago 2
Shenyang 2
Southwark 2
São Paulo 2
Timisoara 2
Tokushima 2
Trento 2
Udine 2
Wandsworth 2
Wuhan 2
Zagreb 2
Athens 1
Baotou 1
Totale 3.960
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 405
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 241
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 234
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 224
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 210
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 208
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 201
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 196
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 188
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 187
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 185
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 185
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 174
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 170
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 169
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 169
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 169
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 167
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 152
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 146
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 146
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 142
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 131
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 130
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 117
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 81
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 79
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 46
Totale 4.852
Categoria #
all - tutte 19.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020970 0 0 20 56 99 149 231 130 106 59 72 48
2020/20211.111 87 57 71 145 200 99 79 97 43 100 58 75
2021/2022628 52 55 49 28 22 57 26 32 62 56 119 70
2022/2023729 77 96 58 74 95 90 10 84 76 5 30 34
2023/2024450 15 19 27 56 80 49 41 65 6 7 35 50
2024/202566 37 25 4 0 0 0 0 0 0 0 0 0
Totale 4.852